Table 2 Top GWS SNPs for each immune biomarker in blood serum.

From: Genome-wide study of immune biomarkers in cerebrospinal fluid and serum from patients with bipolar disorder and controls

Chr

Index SNP

A1/A2

Freq

ß

p-value

N

Position

KB

Genes

Waves

YKL-40

15

rs188263039

T/G

0.988

−76.738

5.80e-26

1

89809787

0

FANCI

1,3

15

rs117809422

A/G

0.015

76.377

7.24e-26

1

89815928

0

FANCI

1,3

15

rs188631178

T/C

0.986

−67.032

1.15e-19

1

89845859

0

FANCI

1,3

10

rs17602253a

T/C

0.988

−65.955

1.79e-18

1

18334915

0

SLC39A12

1,2

15

rs62012778a

A/C

0.966

−37.325

4.41e-15

4

chr15:63818629..63895362

76.73

USP3,FBXL22

1,2,3

1

rs116057745a

A/G

0.982

−31.092

1.47e-14

1

85746632

0

 

1,2,3

16

rs117868506a

T/C

0.013

50.578

7.44e-13

2

chr16:1420638..1428236

7.60

UNKL

2,3

12

rs117843845a

T/C

0.020

47.572

9.12e-13

8

chr12:48287373..48314900

27.527

VDR

1,2

3

rs182265848a

T/G

0.014

58.516

1.05e-12

1

chr3:2579507..2579507

0

CNTN4

2,3

5

rs35017964a

T/C

0.989

−48.149

1.33e-11

1

chr5:73222206..73222206

0

 

2,3

2

rs190160997a

A/C

0.011

45.776

1.58e-10

4

chr2:107295383..107436962

141.579

ST6GAL2

2,3

4

rs116622969a

T/C

0.983

−36.776

2.80e-10

1

chr4:182066384..182066384

0

 

1,2,3

16

rs112260868

A/G

0.012

53.408

3.50e-10

1

chr16:21613268..21613268

0

METTL9

1,3

13

rs150949191a

A/C

0.015

37.114

4.56e-10

2

chr13:109235412..109238352

2.94

 

2,3

1

rs114751860

T/C

0.013

40.152

5.25e-10

1

chr1:85883897..85883897

0

DDAH1

1,3

18

rs172586a

A/G

0.020

46.598

8.46e-10

1

chr18:60321603..60321603

0

 

2,3

18

rs512482a

T/G

0.978

−24.412

8.81e-10

1

chr18:66119026..66119026

0

 

2,3

2

rs186493621a

A/C

0.985

−36.147

9.29e-10

16

chr2:187931545..188399880

468.34

TFPI,CALCRL

2,3

21

rs28707003a

T/C

0.958

−28.903

1.33e-09

12

chr21:15202015..15222754

20.74

 

1,2,3

15

rs67659323a

C/G

0.960

−29,117

2.98e-09

1

chr15:25490757..25490757

0

 

1,2,3

9

rs117574354

C/G

0.015

25.396

3.08e-09

5

chr9:94685768..94923946

238.178

SPTLC1,ROR2

1,3

2

rs150886752a

T/C

0.017

40.299

3.36e-09

2

chr2:47882212..47901294

19.08

 

1,2,3

3

rs34307719a

T/C

0.987

−45,440

3.38e-09

1

chr3:42943216..42943216

0

 

1,2

8

rs960667a

T/G

0.976

−24,890

3.69e-09

5

chr8:126632214..126636054

3.84

 

1,2

2

rs116200463a

T/C

0.013

40.224

6.12e-09

3

chr2:107460348..107488170

27.82

ST6GAL2

2,3

1

rs2290199a

A/G

0.035

20.132

6.21e-09

3

chr1:214825751..214853690

27.94

CENPF

1,2,3

7

rs6969115a

A/G

0.018

35.247

9.34e-09

18

chr7:30250241..30281728

31.49

 

1,2

17

rs4791291a

T/C

0.924

−16,959

1.10e-08

4

chr17:65369397..65396158

26.76

PITPNC1

1,2,3

3

rs192944990a

T/C

0.012

40.733

1.14e-08

2

chr3:43867670..43888114

20.44

 

1,2

16

rs138053699a

A/G

0.019

46.309

1.40e-08

2

chr16:15812581..15821114

8.53

NDE1,MYH11

1,2

2

rs58011745a

A/G

0.035

25.632

1.68e-08

1

chr2:82922195..82922195

0

 

1,2,3

4

rs116608013a

A/C

0.987

−49,182

2.76e-08

1

chr4:2397776..2397776

0

ZFYVE28

1,2

9

rs112153762a

C/G

0.977

−39,896

3.10e-08

4

chr9:98468727..98480513

11.79

 

2,3

19

rs118145918a

T/G

0.024

32.162

3.13e-08

17

chr19:44419463..44487889

68.43

ZNF45,ZNF221

1,2

10

rs113755171a

T/C

0.011

45.313

3.47e-08

1

chr10:34100343..34100343

0

 

2,3

6

rs115196122a

A/G

0.983

−41.511

4.36e-08

3

chr6:159346245..159354145

7.9

 

1,2

7

rs11979716a

T/G

0.022

32.630

4.57e-08

8

chr7:30292334..30320400

28.07

 

1,2

MCP-1

2

chr2_3403609_Da

D/I8

0.033

254.836

1.70e-08

1

3403609

0

TRAPPC12

1,2,3

sCD14

2

rs190197089a

T/C

0.015

700.006

2.27e-09

2

chr2:40635776..40659665

0

SLC8A1

1,2

5

rs2569191a

T/C

0.579

−125.703

7.09e-09

110

139779258..140186438

407.18

ZMAT2,WDR55,TMCO6,SRA1,SLC35A4,PCDHA2,PCDHA3,PCDHA1,NDUFA2,IK,HARS,HARS2,EIF4EBP3,DND1,CD14,APBB3,ANKHD1,ANKHD1-EIF4EBP3

1,2,3

TIMP-1

14

rs118161330

A/G

0.017

−140.235

2.50e-08

1

33801149

0

NPAS3

1,3

TIMP-2

1

chr1_243283251_Da

D/I6

0.018

54.173

1.24e-08

1

243283251

0

 

1,2,3

7

rs117145170a

A/T

0.019

60.350

1.51e-08

1

52273737

0

 

1,2

18

rs150356358a

A/G

0.789

−13.907

2.16e-08

36

10640992..10656164

15

LOC101927410

1,2,3

4

rs114147769a

A/T

0.968

−42.516

2.94e-08

1

162690147

0

FSTL5

2,3

log(CRP)

11

rs57213254

T/C

0.011

3.16

5.51e-09

2

chr11:122678513..122679916

1.40

UBASH3B

1,3

  1. Bold gene names include the index SNP within the gene. Genes not in bold are those that SNPs are closest to. GWS is defined as P < 5e-08. A1/A2, beta(ß), p-value, waves are based on the meta-analysis of GWAS data from each wave. Position is the basepair position or given in UCSC hg19 coordinates.
  2. Chr chromosome, (Index)SNP single nucleotide polymorphism (with the strongest association in the genomic region), A1/A2 reference and alternate allele, Freq weighted average frequency of reference allele, ß random-effects meta-analysis ß estimate, p-value random-effects meta-analysis p-value, N number of SNPs in the reported region, Waves valid waves included for the SNP.
  3. aResults from meta-analysis including wave 2.